157 Results for "

Aldose

" in MedChemExpress (MCE) Product Catalog:
Products (157)

157 Results for "Aldose" in MCE Product Catalog:

35
35 Publications Verification
Cat. No.: HY-N0102
CAS No.: 961-29-5
Synonyms: GU17; ISL; Isoliquiritigen; SJ000286237
Isoliquiritigenin is an anti-tumor flavonoid from the root of Glycyrrhiza uralensis Fisch., which inhibits aldose reductase with an IC50 of 320 nM. Isoliquiritigenin is a potent inhibitor of influenza virus replication with an EC50 of 24.7 μM.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-N0033
CAS No.: 94079-81-9
Poliumoside, a caffeoylated phenylpropanoid glycoside, is isolated from Brandisia hancei stems and leaves. Poliumoside is an advanced glycation end product (AGE) formation and rat lens aldose reductase (RLAR) inhibitor, with IC50s of 19.69 and 8.47 μM, respectively. Poliumoside also has antiinflammatory and antioxidant activity .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-66009
CAS No.: 82159-09-9
Synonyms: ONO2235
Epalrestat is an orally active aldose reductase inhibitor that acts on diabetic neuropathy .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-105185
CAS No.: 136087-85-9
Purity:  99.63%
Synonyms: SNK 860
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Fidarestat (SNK 860) is an inhibitor of aldose reductase, with IC50s of 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10 and V301L AKR1B10, respectively; Fidarestat (SNK 860) has the potential to treat diabetic disease.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1392
CAS No.: 81161-17-3
Esmolol hydrochloride is an ultra-short-acting cardioselective β1-adrenergic blocker. Esmolol hydrochloride exerts its antiarrhythmic effect by activating Neurokinin 1 Receptor. Esmolol hydrochloride attenuates post resuscitation myocardial dysfunction. Esmolol hydrochloride improves diabetic wound healing by inhibiting aldose reductase and the production of advanced glycation end products and promoting fibroblast migration. Esmolol hydrochloride can be used to study cardiac diseases such as arrhythmias and diabetic foot ulcers .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16500
CAS No.: 82964-04-3
Synonyms: AY-27773
Target:  

Aldose Reductase

Research Areas:  

Cancer

Tolrestat is a potent, orally active aldose reductase inhibitor with IC50 of 35 nM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16255
CAS No.: 89391-50-4
Synonyms: AL 1576; Alcon 1576; HOE 843
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-50289
CAS No.: 68367-52-2
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Sorbinil is an aldose reductase inhibitor (ARI) that prevents the accumulation of sorbitol in cells or animals. Sorbinil is useful in studying diabetes and diabetic complications, reducing AR activity and inhibiting the polyol pathway.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13633
CAS No.: 59864-04-9
Purity:  98.03%
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease Cancer

Exisulind is an inactive metabolite of the nonsteroidal, anti-inflammatory agent sulindac . Exisulind inhibits aldose reductase with an IC50 of 367 nM in vitro and may contribute to the beneficial pharmacological effects of sulindac on type 2 diabetic complications .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0311
CAS No.: 23313-21-5
Emodin-8-glucoside is an anthraquinone derivative that can be isolated from Aloe vera. Emodin-8-glucoside is the inhibitor for MAPK with an inhibition constant of 430.14 pM. Emodin-8-glucoside exhibits moderate inhibitory activity against rat lens aldose reductase (ALAR) and topoisomerases II with IC50s of 14.4 μM and 66 μM. Emodin-8-glucoside exhibits antioxidant, anti-inflammatory and anti-fibrotic activities. Emodin-8-glucoside can cross the blood brain barrier .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19687
CAS No.: 110703-94-1
Synonyms: CP73850
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Zopolrestat (CP73850) is a potent, orally active aldose reductase (AR) inhibitor with an IC50 of 3.1 nM. Zopolrestat is used for the research of diabetic complications .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1202
CAS No.: 51411-04-2
Synonyms: AY-22284
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Alrestatin (AY-22284) is an aldose reductase inhibitor. Alrestatin reduces fructose levels in the uterine fluid of mice. Alrestatin interferes with sperm capacitation and impairs fertilization function in mice. Alrestatin decreases basal and tyramine-induced norepinephrine release in rat pancreatic specimens in vitro. Alrestatin enhances glucose- and arginine-stimulated insulin secretion in vivo. Alrestatin can be used in studies related to diabetes and reproductive diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116239
CAS No.: 112733-06-9
Purity:  99.35%
Target:  

Aldose Reductase

Zenarestat is a potent and orally active aldose reductase inhibitor. Zenarestat improves diabetic peripheral neuropathy in Zucker diabetic fatty rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-106697
CAS No.: 72702-95-5
Purity:  99.51%
Synonyms: ICI 128436
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Ponalrestat (ICI 128436) is an orally active, selective and noncompetitive aldose reductase (AKR1B1; ALR) inhibitor. Ponalrestat selectively inhibits ALR2 (Ki=7.7 nM) over ALR1 (Ki=60 μM). Ponalrestat inhibits the conversion of glucose to sorbitol .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15314
CAS No.: 147254-64-6
Purity:  96.10%
Synonyms: AS-3201
Target:  

Aldose Reductase

Ranirestat (AS-3201) potent and orally active aldose reductase (AR) inhibitor with IC50s of 11 nM and 15 nM for rat lens AR and recombinant human AR, respectively, and a Ki of 0.38 nM for recombinant human AR. Ranirestat has the potential for diabetic sensorimotor polyneuropathy treatment. Ranirestat also has a neuroprotective effect on diabetic retinas .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0309
CAS No.: 114590-20-4
Soyasaponin Ba is a soyasaponin that can be isolated from Phaseolus vulgaris, acts as an aldose reductase inhibitor (ARI). Soyasaponin Ba activates Akt/GSK3β/β-catenin signaling pathway, reduces lipid accumulation, lowers ROS generation, improves mitochondrial membrane potential, ATP levels, and morphology, and inhibits apoptosis. Soyasaponin Ba can be used for the research of lipid accumulation and secondary diabetic complications .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133708
CAS No.: 13405-60-2
Purity:  99.82%
Synonyms: Glucogallin; 1-O-Galloyl-β-D-glucose
β-Glucogallin is an orally active and selective aldose reductase (AKR1B1) inhibitor with an IC50 value of 58 μM when using Glyceraldehyde (HY-128748) as AKR1B1 substrate. β-Glucogallin reduces ROS, PDGF, RAGE, and NF-κB. β-Glucogallin increases SOD. β-Glucogallin has antioxidant and hepatoprotective effects. β-Glucogallin can be used in retinal research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0310
CAS No.: 51330-27-9
Soyasaponin Bb is an orally active, covalent inducer of heme oxygenase HO-1 and an inhibitor of aldose reductase AKR1B1. Soyasaponin Bb can regulate oxidative stress pathways, enhance antioxidant capacity, reduce reactive oxygen species (ROS) generation, and inhibit lipid peroxidation and hepatocyte apoptosis. Soyasaponin Bb improves alcohol-induced hepatocyte membrane damage and liver function abnormalities, and improves Scopolamine (HY-N0296)-induced memory impairment. Soyasaponin Bb has antioxidant, hepatoprotective, and neuroprotective activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-Y0790
CAS No.: 122-03-2
Synonyms: p-Isopropylbenzaldehyde
Cuminaldehyde is the main component of Cuminum cyminum and has multiple biological activities, including anti-inflammatory, anti-cancer, anti-diabetic, anti-injury, anti-neuropathy and antibacterial effects. Cuminaldehyde is an inhibitor of aldose reductase (IC50= 0.00085 mg/mL), α-glucosidase (IC50=0.5 mg/mL) and lipoxygenase (IC50=1370 μM). Cuminaldehyde also inhibits the fibrillation of α-synuclein and prevents its aggregation. Cuminaldehyde has potential application value in the research of neurodegenerative diseases, cancer, diabetes and neuropathic pain diseases .
loading...
    loading...
Cat. No.: HY-128748
CAS No.: 56-82-6
Purity:  ≥90.0%
DL-Glyceraldehyde is a bioactive substance involved in cellular energy metabolism and a key intermediate in sugar metabolism pathways (such as glycolysis and gluconeogenesis). During glycolysis, DL-Glyceraldehyde is converted by enzymes into other metabolites to provide energy for cells; during gluconeogenesis, DL-Glyceraldehyde participates in the synthesis of glucose as a precursor. In the field of medical research, DL-Glyceraldehyde can be used to study diseases related to sugar metabolism, such as diabetes, tumors, etc[1][2].
loading...
    loading...